HomeCOYA • NASDAQ
add
Coya Therapeutics Inc
Previous close
$4.18
Day range
$3.91 - $4.18
Year range
$3.91 - $7.75
Market cap
92.89M USD
Avg Volume
122.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.96M | 202,768.80% |
Operating expense | 3.28M | 52.78% |
Net income | -5.71M | -95.78% |
Net profit margin | -144.16 | 99.90% |
Earnings per share | -0.34 | -88.89% |
EBITDA | -4.25M | -4.34% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 46.82M | 22.13% |
Total assets | 49.95M | 12.63% |
Total liabilities | 6.92M | 45.12% |
Total equity | 43.03M | — |
Shares outstanding | 23.46M | — |
Price to book | 2.03 | — |
Return on assets | -25.96% | — |
Return on capital | -30.27% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.71M | -95.78% |
Cash from operations | -1.01M | 58.21% |
Cash from investing | -648.61K | — |
Cash from financing | 20.35M | 109.95% |
Net change in cash | 18.69M | 156.69% |
Free cash flow | 784.54K | 144.40% |
About
Founded
2020
Headquarters
Website
Employees
8